Use of gasotransmitters for the controlled release of polymer-based nitric oxide carriers in medical applications

J Control Release. 2018 Jun 10:279:157-170. doi: 10.1016/j.jconrel.2018.04.025. Epub 2018 Apr 16.

Abstract

Nitric Oxide (NO) is a small molecule gasotransmitter synthesized by nitric oxide synthase in almost all types of mammalian cells. NO is synthesized by NO synthase by conversion of l-arginine to l-citrulline in the human body. NO then stimulates soluble guanylate cyclase, from which various physiological functions are mediated in a concentration-dependent manner. High concentrations of NO induce apoptosis or antibacterial responses whereas low NO circulation leads to angiogenesis. The bidirectional effect of NO has attracted considerable attention, and efforts to deliver NO in a controlled manner, especially through polymeric carriers, has been the topic of much research. This naturally produced signaling molecule has stood out as a potentially more potent therapeutic agent compared to exogenously synthesized drugs. In this review, we will focus on past efforts of using the controlled release of NO via polymer-based materials to derive specific therapeutic results. We have also added studies and our future suggestions on co-delivery methods with other gasotransmitters as a step towards developing multifunctional carriers.

Keywords: Carbon monoxide; Crosstalk of gasotransmitters; Hydrogen sulfide; Nitric oxide; Polymeric carrier; Stimuli-responsive.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Apoptosis / physiology
  • Delayed-Action Preparations
  • Gasotransmitters / metabolism*
  • Humans
  • Nitric Oxide / metabolism*
  • Polymers / chemistry*
  • Signal Transduction / physiology

Substances

  • Delayed-Action Preparations
  • Gasotransmitters
  • Polymers
  • Nitric Oxide